Idelalisib plus an anti-Cd20 antibody in patients with chronic lymphocytic leukemia (CLL) who are HBV core antibody positive: Similar patterns of liver test abnormalities Meeting Abstract

   


Authors: Robak, T.; Zelenetz, A. D.; Mato, A.; Jones, J. A.; Pagel, J. M.; Barrientos, J. C.; Brown, J. R.; Montillo, M.; Dubowy, R.; Xing, G.; Li, J. J.; Kipps, T. J.; Hillmen, P.
Abstract Title: Idelalisib plus an anti-Cd20 antibody in patients with chronic lymphocytic leukemia (CLL) who are HBV core antibody positive: Similar patterns of liver test abnormalities
Meeting Title: 21st Congress of the European Hematology Association (EHA)
Keywords: rituximab; reactivation; hepatitis-b
Journal Title: Haematologica
Volume: 101
Issue: Suppl. 1
Meeting Dates: 2016 Jun 9-12
Meeting Location: Copenhagen, Denmark
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2016-06-01
Start Page: 437
Language: English
ACCESSION: WOS:000379484601440
PROVIDER: wos
PMCID: PMC4894295
Notes: Meeting Abstract: E1063 -- Source: Wos